{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:35:18Z","timestamp":1772159718494,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T00:00:00Z","timestamp":1555632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T00:00:00Z","timestamp":1555632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1007\/s12325-019-00951-4","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T19:02:57Z","timestamp":1555700577000},"page":"1485-1496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study)"],"prefix":"10.1007","volume":"36","clinical-trial-number":[{"clinical-trial-number":"nct03243903","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"LiNong","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LiMing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YanGang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZhongShu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XingWu","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZiLin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiangJin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GuiXia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LiXin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZhongYan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,19]]},"reference":[{"key":"951_CR1","unstructured":"IDF Diabetes Atlas, 8th edition, 2017. https:\/\/www.idf.org\/e-library\/epidemiology-research\/diabetes-atlas\/134-idf-diabetes-atlas-8th-edition.html. Accessed 1 Jan 2019."},{"key":"951_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2337\/dbi17-0013","volume":"67","author":"C Hu","year":"2018","unstructured":"Hu C, Jia W. Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes. 2018;67:3\u201311.","journal-title":"Diabetes"},{"issue":"12","key":"951_CR3","first-page":"740","volume":"9","author":"Chinese Diabetes Society Diabetes Education and Management Group","year":"2017","unstructured":"Chinese Diabetes Society Diabetes Education and Management Group. Type 2 diabetes self-management prescription expert consensus in China. Chin J Diabetes Mellit. 2017;9(12):740\u201350.","journal-title":"Chin J Diabetes Mellit"},{"key":"951_CR4","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1056\/NEJMoa066224","volume":"355","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Haffner SM, Heise MA, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med. 2006;355:2427\u201343.","journal-title":"N Engl J Med"},{"key":"951_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2337\/diacare.27.1.17","volume":"27","author":"CE Koro","year":"2004","unstructured":"Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care. 2004;27:17\u201320.","journal-title":"Diabetes Care"},{"key":"951_CR6","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","volume":"281","author":"RC Turner","year":"1999","unstructured":"Turner RC, Cull CA, Frighi V, Holman RR, UK Prospective Diabetes Study (UKPDS) Group. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA. 1999;281:2005\u201312.","journal-title":"JAMA"},{"key":"951_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ajme.2017.05.010","volume":"54","author":"GM Rwegerera","year":"2018","unstructured":"Rwegerera GM, Moshomo T, Gaenamong M, et al. Health-related quality of life and associated factors among patients with diabetes mellitus in Botswana. Alex J Med. 2018;54:111\u20138.","journal-title":"Alex J Med"},{"key":"951_CR8","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.2337\/diacare.28.10.2543","volume":"28","author":"WH Polonsky","year":"2005","unstructured":"Polonsky WH, Fisher L, Guzman S, et al. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005;28:2543\u20135.","journal-title":"Diabetes Care"},{"issue":"Suppl B","key":"951_CR9","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1016\/j.clinthera.2005.11.019","volume":"27","author":"M Korytkowski","year":"2005","unstructured":"Korytkowski M, Niskanen L, Asakura T. FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther. 2005;27(Suppl B):S89\u2013100.","journal-title":"Clin Ther"},{"key":"951_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4103\/ijem.IJEM_548_16","volume":"21","author":"MP Baruah","year":"2017","unstructured":"Baruah MP, Kalra S, Bose S, Deka J. An audit of insulin usage and insulin injection practices in a large Indian cohort. Indian J Endocrinol Metab. 2017;21:443\u201352.","journal-title":"Indian J Endocrinol Metab"},{"key":"951_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/dia.2016.0334","volume":"19","author":"L Ji","year":"2017","unstructured":"Ji L, Sun Z, Li Q, et al. Lipohypertrophy in China: prevalence, risk factors, insulin consumption, and clinical impact. Diabetes Technol Ther. 2017;19:61\u20137.","journal-title":"Diabetes Technol Ther"},{"key":"951_CR12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1080\/17425247.2016.1198772","volume":"13","author":"J Hu","year":"2016","unstructured":"Hu J, Shi H, Zhao C, et al. Lispro administered by the QS-M needle-free jet injector generates an earlier insulin exposure. Expert Opin Drug Deliv. 2016;13:1203\u20137.","journal-title":"Expert Opin Drug Deliv"},{"key":"951_CR13","doi-asserted-by":"publisher","first-page":"e5482","DOI":"10.1097\/MD.0000000000005482","volume":"96","author":"L Guo","year":"2017","unstructured":"Guo L, Xiao X, Sun X, Qi C. Comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients. Medicine. 2017;96:e5482 (Baltimore).","journal-title":"Medicine"},{"key":"951_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1089\/dia.2015.0054","volume":"17","author":"L Ji","year":"2015","unstructured":"Ji L, Zhang P, Weng J, et al. Observational registry of basal insulin treatment (ORBIT) in patients with type 2 diabetes uncontrolled by oral hypoglycemic agents in China\u2014study design and baseline characteristics. Diabetes Technol Ther. 2015;17:735\u201344.","journal-title":"Diabetes Technol Ther"},{"key":"951_CR15","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1089\/152091502321118865","volume":"4","author":"MJ Sarno","year":"2002","unstructured":"Sarno MJ, Bell J, Edelman SV. Pharmacokinetics and glucodynamics of rapid-, short-, and intermediate-acting insulins: comparison of jet injection to needle syringe. Diabetes Technol Ther. 2002;4:863\u20136.","journal-title":"Diabetes Technol Ther"},{"key":"951_CR16","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.2337\/dc11-0182","volume":"34","author":"EE Engwerda","year":"2011","unstructured":"Engwerda EE, Abbink EJ, Tack CJ, de Galan BE. Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology. Diabetes Care. 2011;34:1804\u20138.","journal-title":"Diabetes Care"},{"key":"951_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1463-1326.2012.01666.x","volume":"15","author":"BE de Galan","year":"2013","unstructured":"de Galan BE, Engwerda EE, Abbink EJ, Tack CJ. Body mass index and the efficacy of needle-free jet injection for the administration of rapid-acting insulin analogs, a post hoc analysis. Diabetes Obes Metab. 2013;15:84\u20136.","journal-title":"Diabetes Obes Metab"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-00951-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-019-00951-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-00951-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:25:27Z","timestamp":1628612727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-019-00951-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,19]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6,1]]}},"alternative-id":["951"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-00951-4","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,19]]},"assertion":[{"value":"12 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}